lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
cuprous iodide basic information |
physical and chemical properties using limited production method |
product name: | cuprous iodide |
synonyms: | copper iodide (cui);cui;hydro-giene;marshite;copper(+1)iodide;copper iodide;copper(i) iodide;ciras |
cas: | 7681-65-4 |
mf: | cui |
mw: | 190.45 |
einecs: | 231-674-6 |
product categories: | inorganics;metal halide |
mol file: | 7681-65-4.mol |
cuprous iodide chemical properties |
mp | 605 °c(lit.) |
bp | 1290 °c |
density | 5.62 g/ml at 25 °c(lit.) |
vapor pressure | 10 mm hg ( 656 °c) |
refractive index | 2.346 |
fp | 1290°c |
water solubility | insoluble |
sensitive | air & moisture sensitive |
merck | 14,2662 |
cas database reference | 7681-65-4(cas database reference) |
nist chemistry reference | copper iodide (cui)(7681-65-4) |
safety information |
hazard codes | xn,n,xi |
risk statements | 22-36/37/38-50/53 |
safety statements | 22-24/25-26-61 |
ridadr | un 3077 9/pg 3 |
wgk germany | 3 |
f | 8 |
hs code | 28276000 |
hazardous substances data | 7681-65-4(hazardous substances data) |